Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
adverse drug reaction
anemia
bevacizumab
blood transfusion
carotid artery atherosclerosis
carotid artery stenosis
CAT scan
CAT scan, abnormal
CAT scan, delta sign, empty
cerebral blood flow
cerebral infarction, hemorrhagic
cerebral ischemia
cerebral venous infarction
cerebral venous thrombosis
cerebrovascular accident
cerebrovascular disease, risk factors in
complications
cycling
dialysis
doping
doppler
doppler, transcranial
drug abuse
drug induced neurologic disorders
dural sinus thrombosis
encephalopathy
erythropoietin
erythropoietin treatment
flow study, cerebral
hallucination
hallucination, visual
headache
headache, progressive
hormone replacement
hypertension
hypertensive encephalopathy
hyperviscosity
iatrogenic neurologic disorders
intracerebral hemorrhage
intracerebral hemorrhage, multiple
leukoencephalopathy
mental status, evaluation of
mortality
MRI
MRI, abnormal
MRI, angiography
MRI, venography
myelodysplasia
oral contraceptives
oral contraceptives, cerbrovascular disease and
polycythemia, secondary
posterior leukoencephalopathy syndrome
premarin
psychological testing
quality of life
renal failure
review article
risk-benefit assessment
seizure
sports medicine, neurology of
strokelike episodes
superior sagittal sinus thrombosis
tamoxifen
treatment of neurologic disorder
uremia
Showing articles 0 to 50 of 1802 Next >>

Drugs Associated with Ischemic Stroke
Stroke 52:e646-e659, Marto, J.P.,et al, 2021

Cyclists doping associated with cerebral sinus thrombosis
Neurol 58:665, Martinez Lage, J.M.,et al, 2002

Cyclists' Doping Associated with Cerebral Sinus Thrombosis
Neurol 58:665, Lage,J.M.M.,et al, 2002

Cerebral Venous Thrombosis Associated with Epoetin Alfa Therapy
Arch Neurol 57:260-262, Finelli,P.F.&Carley,M.D., 2000

Myelodysplastic Syndrome and Sagittal Sinus Thrombosis
J Stroke Cerebrovasc Dis 7:211-212, Finelli,P.F.,et al, 1998

Erythropoietin-Associated Hypertensive Posterior Leukoencephalopathy
Neurol 49:686-689, Delanty,N.,et al, 1997

Recombinant Human Erythropoietin and Renal Anemia:Molecular Biology, Clinical Efficacy, and Nervous System Effects
Ann Int Med 114:402-416, Nissenson,A.R.,et al, 1991

Erythropoeitin and Visual Hallucinations
NEJM 325:285, Steinberg,H., 1991

Changes in Middle Cerebral Artery Blood Velocity in Uremic Patients after Hemodialysis
Stroke 22:1508-1511, Postiglione,A.,et al, 1991

Seizures Related to Blood Transfusion and Erythropoietin Treatment in Patients Undergoing Dialysis
BMJ 299:1258-1259, Brown,A.L.,et al, 1989

Acromegaly
NEJM 393:1926-1939, Giustina,A. & Colao,A.,, 2025

A 41-year-old man with Thunderclap Headache
Neurol 91:e87-e91, Grossman, S.et al, 2018

NT-3 Promotes Nerve Regeneration and Sensory Improvement in CMT1A Mouse Models and in Patients
Neurol 65:681-689, 662, Sahenk,Z.,et al, 2005

Recombinant Human Nerve Growth Factor in the Treatment of Diabetic Polyneuropathy
Neurol 51:695-702, 6621998., Apfel,S.C.,et al, 1998

Long-Term Octreotide Therapy in Growth Hormone-Secreting Pituitary Adenomas:Evaluation with Serial MR
AJNR 18:765-772, Lundin,P.,et al, 1997

Nerve Growth Factor and Diabetic Neuropathy
Lancet 348:1044-1045, Dyck,P.J., 1996

Growth Factors:Potential Therapeutic Applications in Neurology
JNNP 54:1445-1450, Drago,J.,et al, 1994

Persistence of Initial Infection in Recurrent Cryptococcus Neuformans Meningitis
Lancet 341:595-596, Spitzer,E.D.,et al, 1993

AIDS-Assoc Progressive Multifocal Leukoencephalopathy (PML) :Comparison to Non-AIDS PML
Neurol 40:1073-1078, Aksamit,A.J.,et al, 1990

Neurofibromatosis 2 (Bilateral Acoustic Neuro-fibromatosis)
NEJM 318:684-688, Martuza,R.L.&Eldridge,R., 1988

Transplantation in Parkinson's Disease:Two Cases of Adrenal Medullary Grafts to the Putamen
Ann Neurol 22:457-468, Lindvall,O.,et al, 1987

Nerve Growth Factor (three parts)
NEJM 297:1096, 1149, 1211977., Mobley,W.C.,et al, 1977

Nerve-Growth Factor in Familial Dysautonomia
NEJM 295:671, Montalcini,R.L., 1976

Increased Nerve-growth Stimulating Activity in Disseminated Neurofibromatosis
NEJM 290:613, 1974, 290:626974., Schenkein,I.,et al, 1974

Systematic Genetic Assessment in Young Patients with Cryptogenic Stroke: The ES-EASY Project
Stroke 57:148-156, Mania-Paris,L.,et al, 2026

A 41-Year-Old Man with Steroid-Responsive Hemiparesis
Neurol 106:e214088, Obaidi,Z.A.,et al, 2026

Progressive Quadriparesis and Falls in a 66-Year-Old Man With Longstanding Human Immunodeficiency Virus
Neurol 106:e214621, Ong,B.A. & Carlson,A.K., 2026

Intravenous Thrombolysis Use in the Late Time Window Before Interhospital Transfer for Thrombectomy
JAMA Neurol 83:60-67, Seners,P.,et al, 2026

Intravenous Thrombolysis Use Before Inter-Facility Transfer for Thrombectomy:Association with Efficacy and Safety Outcomes
Ann Neurol 98:871-880, Seners,P.,et al, 2025

Effectiveness and Safety of IV Thrombolysis Before Hospital Transfer for Thrombectomy in Patients With Basilar Artery Occlusion
Neurol 105:e214355, Liebart,S.,et al, 2025

A 30-Year-Old Female Patient with Multiple Sclerosis Presenting with Rapidly Progressive Cranial Neuropathies, Weakness, and Ataxia
Neurol 105:e214429, Trentadue,T.,et al, 2025

Ribbon-Like Cortical Calcifications in Hereditary Cerebral Hemorrhage With Amyloidosis-Dutch Type
Neurol 106:e214464, Chen,Y.,et al, 2025

Upbeat Nystagmus From Dorsolateral Pontine Hemorrhagic Transformation
Neurol 106:e214467, Chen,H. & Li, J., 2025

A 62-Year-Old Man with Progressive Limb Weakness, Involuntary Movements, and HyperCKemia
JAMA Neurol 82L:1286-1287, Liu,Y.,et al, 2025

A 62-Year-Old Woman with Progressive Spasticity, Weakness,and Gait Instability
Neurol 104:e210290, Voloshyna-Farber, E.Y.,et al, 2025

Efficacy and Safety of IV Thrombolysis for Acute Ischemic Stroke Patients with Moyamoya Disease
Neurol 104:e210243, Chen,H.,et al, 2025

Endovascular Thrombectomy for Extracranial Internal Carotid Artery Occlusions with Large Ischemic Strokes
Neurol 104:e210269, Ortega-Gutierrez,S.,et al, 2025

A 26-Year-OldWoman with Headache and Eosinophilia
Neurol 104:e213434, Goh,W.G.W.,et al, 2025

Endovascular Therapy for Patients with Low NIHSS Scores and Large Vessel Occlusion in the 6- to 24-Hour Window
Neurol 104:e213442, Marto,J.P.,et al, 2025

Alteplase for Posterior Circulation Ischemic Stropke at 4.5 to 24 Hours
NEJM 392:1288-1296, Yan,S.,et al, 2025

"Innumerable" lesion burden on brain MRI - a diagnostic approach
Diagnosis doi.org/10.1515/dx- 2025-2029, Finelli,P.F., 2025

Endovascular Treatment of Stroke Due to Medium-Vessel Occlusion
NEJM 392:1385-1395,1440, Goyal,lM.,et al, 2025

Endovascular Treatment for Stroke Due to Occlusion of Medium or Distal Vessels
NEJM 392:1374-1384,1440, Psychogios,M.,et al, 2025

Endovascular Thrombectomy for Large Ischemic Core Stroke, A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Neurol 104:e213443, Liu,C.,et al, 2025

A Toddler with Acute-Onset Hypotonia, Areflexia, and Ataxia
Neurol 104:e213593, Pence, K.L. &Clark, R.A., 2025

General AI May Revolutionize Neurology 0 Or It Might be Bad
JAMA Neurol doi 10.1001/JAMANEUROL.2025.0905, Westover,M.B. & Westover,A.M., 2025

Abnormal and Persistent Mineralization of Globi Pallidi in GAMT Deficiency
Neurol 104:e213636, Chanda,G.,et al, 2025

Intravenous Tenecteplase before Thrombectomy in Stroke
NEJM 393:139-150, Qiu,Z.,et al, 2025

Endovascular Treatment in Acute Ischemic Stroke Due to Occlusion of Medium or Distal Vessels
Neurol 105:e214015, Palaiodimou,L.,et al, 2025



Showing articles 0 to 50 of 1802 Next >>